Glossary entry (derived from question below)
French term or phrase:
chimio aplasiante
English translation:
cytotoxic chemotherapy
Added to glossary by
Jason Willis-Lee
Sep 28, 2005 10:05
18 yrs ago
4 viewers *
French term
aplasiante
French to English
Other
Medical: Health Care
oncology: CT and RT
Health care research Q&As. Oncologists asked to fill in a questionnaire on their clinical habits....appears in the following context. TIA, Jason.
chimio aplasiante et radiotherapie sur un terrain general altere
chimio aplasiante et radiotherapie sur un terrain general altere
Proposed translations
(English)
4 +2 | cytotoxic chemotherapy | Dr Sue Levy (X) |
5 +1 | aplasia-inducing | Georges Tocco |
3 | aplasing | Emérentienne |
Change log
Sep 28, 2005 10:07: Anabel Martínez changed "Language pair" from "Spanish to English" to "French to English"
Proposed translations
+2
23 mins
Selected
cytotoxic chemotherapy
My first thought was aplasia-inducing chemotherapy, but the few references to this in English made me wonder. Certainly, in some French texts, "chimiothérapie aplasiante" refers specifically to the induction of bone marrow aplasia, for example, in preparation for a BM transplant. But otherwise it seems to be a general term for what we would call in English, cytotoxic chemotherapy.
--------------------------------------------------
Note added at 7 hrs 21 mins (2005-09-28 17:26:38 GMT)
--------------------------------------------------
In relation to bone marrow transplants, "high-dose chemotherapy".
--------------------------------------------------
Note added at 22 hrs 34 mins (2005-09-29 08:40:06 GMT)
--------------------------------------------------
In fact only 11 articles with "aplasia-inducing" turn up with a Google search. Three of these are by the same authors (Horn et al). About half are translations from other languages (French or German).
--------------------------------------------------
Note added at 7 hrs 21 mins (2005-09-28 17:26:38 GMT)
--------------------------------------------------
In relation to bone marrow transplants, "high-dose chemotherapy".
--------------------------------------------------
Note added at 22 hrs 34 mins (2005-09-29 08:40:06 GMT)
--------------------------------------------------
In fact only 11 articles with "aplasia-inducing" turn up with a Google search. Three of these are by the same authors (Horn et al). About half are translations from other languages (French or German).
4 KudoZ points awarded for this answer.
Comment: "Thanks Sue...."
23 mins
aplasing
An open phase I study assessing the feasibility of the triple ... - [ Traduire cette page ]
... previous antitumor treatment for at least 4 weeks (6 weeks in the case of
aplasing chemotherapy such as nitrosourea, mitomycin C and carboplatin). ...
annonc.oxfordjournals.org/cgi/content/full/14/3/481 - Pages similaires
... previous antitumor treatment for at least 4 weeks (6 weeks in the case of
aplasing chemotherapy such as nitrosourea, mitomycin C and carboplatin). ...
annonc.oxfordjournals.org/cgi/content/full/14/3/481 - Pages similaires
+1
5 hrs
aplasia-inducing
aplasia-inducing chemotherapy
see:
Histiocytofibromes multiples éruptifs.
Alors que l’histiocytofibrome est banal, les HCF multiples sont rares. On les a décrits dans des situations de déficit immunitaire comme les collagénoses et maladies auto-immunes, l’infection par le VIH ou la corticothérapie générale. C’est ici le second cas rapporté en association à une leucémie myéloïde chronique. Dans les mois suivant une CHIMIOTHERAPIE APLASIANTE par le busulfan sont apparus 13 HCF. La dépression de l’immunité cellulaire était manifeste puisque le patient a fait à la même période une pneumopathie et une candidose, et qu’il avait une lymphopénie globale, des intradermoréactions négative à la tuberculine et à la candidine et un taux abaissé d’anticorps circulants contre les antigènes de groupes sanguins. Après la récupération médullaire, les HCF ont régressé progressivement en deux mois et aucune nouvelle lésion n’est plus apparue.
Multiple eruptive dermatofibromas.
While dermatofibroma is common, multiple dermatofibromas (MDFs) are rare. They have been described in situations of immune deficiency such as collagenosis and self-immune diseases, HIV-induced infection or systemic corticotherapy. This case report is the second to report association with chronic myelogenous leukemia. 13 MDFs appeared during the months that followed APLASIA-INDUCING CHEMOTHERAPY using busulfan. Depression in cellular immunity was obvious as the patient simultaneously developed pneumopathy and candidosis, as well as presented global lymphopenia, intradermoreactions that did not respond to tuberculin and candidin, and a decreased level of circulating antibodies against blood group antigens. After medullary recovery, MDFs progressively receded two months later without the appearance of new lesions.
see:
Histiocytofibromes multiples éruptifs.
Alors que l’histiocytofibrome est banal, les HCF multiples sont rares. On les a décrits dans des situations de déficit immunitaire comme les collagénoses et maladies auto-immunes, l’infection par le VIH ou la corticothérapie générale. C’est ici le second cas rapporté en association à une leucémie myéloïde chronique. Dans les mois suivant une CHIMIOTHERAPIE APLASIANTE par le busulfan sont apparus 13 HCF. La dépression de l’immunité cellulaire était manifeste puisque le patient a fait à la même période une pneumopathie et une candidose, et qu’il avait une lymphopénie globale, des intradermoréactions négative à la tuberculine et à la candidine et un taux abaissé d’anticorps circulants contre les antigènes de groupes sanguins. Après la récupération médullaire, les HCF ont régressé progressivement en deux mois et aucune nouvelle lésion n’est plus apparue.
Multiple eruptive dermatofibromas.
While dermatofibroma is common, multiple dermatofibromas (MDFs) are rare. They have been described in situations of immune deficiency such as collagenosis and self-immune diseases, HIV-induced infection or systemic corticotherapy. This case report is the second to report association with chronic myelogenous leukemia. 13 MDFs appeared during the months that followed APLASIA-INDUCING CHEMOTHERAPY using busulfan. Depression in cellular immunity was obvious as the patient simultaneously developed pneumopathy and candidosis, as well as presented global lymphopenia, intradermoreactions that did not respond to tuberculin and candidin, and a decreased level of circulating antibodies against blood group antigens. After medullary recovery, MDFs progressively receded two months later without the appearance of new lesions.
Something went wrong...